New Zealand markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
598.85+0.24 (+0.04%)
At close: 04:00PM EDT
597.49 -1.36 (-0.23%)
Pre-market: 04:32AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
6,220,000
5,995,000
6,950,000
7,725,000
6,375,000
-
Depreciation & amortisation
3,319,000
3,406,000
3,381,000
2,592,000
2,325,000
-
Deferred income taxes
-1,579,000
-1,300,000
-995,000
-647,000
-552,000
-
Stock-based compensation
282,000
278,000
307,000
230,000
196,000
-
Change in working capital
753,000
-495,000
-1,008,000
-1,514,000
-299,000
-
Accounts receivable
-
-43,000
-430,000
-204,000
-1,302,000
-
Inventory
-
598,000
-825,000
-1,065,000
-508,000
-
Accounts payable
-
-500,000
648,000
479,000
59,000
-
Other working capital
7,963,000
6,927,000
6,911,000
6,789,000
6,815,000
-
Other non-cash items
387,000
562,000
483,000
156,000
242,000
-
Net cash provided by operating activities
9,348,000
8,406,000
9,154,000
9,312,000
8,289,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,385,000
-1,479,000
-2,243,000
-2,523,000
-1,474,000
-
Acquisitions, net
-909,000
-3,660,000
-39,000
-19,395,000
-38,000
-
Sales/maturities of investments
146,000
70,000
15,000
8,000
-
-
Other investing activities
-199,000
-160,000
84,000
-42,000
-6,000
-
Net cash used for investing activities
-3,840,000
-5,142,000
-2,159,000
-21,932,000
-1,510,000
-
Cash flows from financing activities
Debt repayment
-5,276,000
-7,717,000
-4,065,000
-11,738,000
-1,097,000
-
Common stock issued
-
-
-
-
-
0
Common stock repurchased
-3,000,000
-3,000,000
-3,000,000
-2,000,000
-1,500,000
-
Dividends paid
-555,000
-523,000
-455,000
-395,000
-337,000
-
Other financing activities
176,000
56,000
-9,000
65,000
-150,000
-
Net cash used provided by (used for) financing activities
-1,508,000
-3,622,000
-2,810,000
6,581,000
959,000
-
Net change in cash
3,944,000
-440,000
4,046,000
-5,845,000
7,914,000
-
Cash at beginning of period
3,153,000
8,537,000
4,491,000
10,336,000
2,422,000
-
Cash at end of period
7,153,000
8,097,000
8,537,000
4,491,000
10,336,000
-
Free cash flow
Operating cash flow
9,348,000
8,406,000
9,154,000
9,312,000
8,289,000
-
Capital expenditure
-1,385,000
-1,479,000
-2,243,000
-2,523,000
-1,474,000
-
Free cash flow
7,963,000
6,927,000
6,911,000
6,789,000
6,815,000
-